Promising Clinical Trial Results For A Mesothelioma Immunotherapy Drug
Promising results from another phase of a clinical trial for an immunotherapy drug for mesothelioma, CRS-207, have been released.
Category: U.S. Food and Drug Administration
Promising Lung Cancer Vaccine From Cuba At Roswell Park Cancer Institute
Roswell Park Cancer Institute is working on a promising lung cancer vaccine from Cuba that will be submitted for FDA approval.
Johnson & Johnson To Pay $72M In Talcum Powder Case
A Missouri state jury awarded an ovarian-cancer victim $72 million to be paid by Johnson & Johnson because of their talcum powder product.
FDA-Approved Keytruda Treatment Could Help Mesothelioma Patients
Recently, the FDA approved Merck immunotherapy drug Keytruda for treatment in non-small cell lung cancer and is bringing hope to mesothelioma patients.